Published in J Public Health Policy on November 22, 2012
EPMA position paper in cancer: current overview and future perspectives. EPMA J (2015) 1.04
Conceptualising the public health role of actors operating outside of formal health systems: The case of social enterprise. Soc Sci Med (2016) 0.75
Action on the social determinants of health through social enterprise. CMAJ (2017) 0.75
The assets-based approach: furthering a neoliberal agenda or rediscovering the old public health? A critical examination of practitioner discourses. Crit Public Health (2016) 0.75
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med (2002) 2.69
Health care priority setting: principles, practice and challenges. Cost Eff Resour Alloc (2004) 2.59
Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13
Setting priorities and allocating resources in health regions: lessons from a project evaluating program budgeting and marginal analysis (PBMA). Health Policy (2003) 1.91
Guiding the design and selection of interventions to influence the implementation of evidence-based practice: an experimental simulation of a complex intervention trial. Soc Sci Med (2004) 1.91
Setting priorities in Canadian regional health authorities: a survey of key decision makers. Health Policy (2002) 1.83
Making the playfields even: evaluating the impact of an environmental intervention on park use and physical activity. Prev Med (2009) 1.82
The FtsK gamma domain directs oriented DNA translocation by interacting with KOPS. Nat Struct Mol Biol (2006) 1.76
Special care facility compared with traditional environments for dementia care: a longitudinal study of quality of life. J Am Geriatr Soc (2004) 1.71
Economics and obesity: costing the problem or evaluating solutions? Obes Res (2004) 1.63
Programme budgeting and marginal analysis: bridging the divide between doctors and managers. BMJ (2005) 1.52
Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy (2006) 1.52
Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci (2009) 1.45
A feasibility study of transcutaneous posterior tibial nerve stimulation for bladder and bowel dysfunction in elderly adults in residential care. J Am Med Dir Assoc (2012) 1.45
Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE. Health Econ Policy Law (2011) 1.42
Dissection of a functional interaction between the DNA translocase, FtsK, and the XerD recombinase. Mol Microbiol (2006) 1.34
Using economics to set pragmatic and ethical priorities. BMJ (2006) 1.33
Deriving distributional weights for QALYs through discrete choice experiments. J Health Econ (2011) 1.24
Priority setting in a Canadian surgical department: a case study using program budgeting and marginal analysis. Can J Surg (2003) 1.24
Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol (2004) 1.24
Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism? Soc Sci Med (2003) 1.24
Managing to manage healthcare resources in the English NHS? What can health economics teach? What can health economics learn? Health Policy (2007) 1.22
Economic evaluation of weight loss interventions in overweight and obese women. Obesity (Silver Spring) (2006) 1.20
Using PBMA in health care priority setting: description, challenges and experience. Appl Health Econ Health Policy (2003) 1.19
Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med (2004) 1.19
The health-care system: an assessment and reform agenda. Lancet (2009) 1.19
Priority setting in health authorities: a novel approach to a historical activity. Soc Sci Med (2003) 1.17
The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs gross-costing approaches. Health Econ (2009) 1.14
The social value of a QALY: raising the bar or barring the raise? BMC Health Serv Res (2011) 1.13
Clinical and economic evaluation of rapid influenza a virus testing in nursing homes in calgary, Canada. Clin Infect Dis (2002) 1.10
Best worst discrete choice experiments in health: methods and an application. Soc Sci Med (2012) 1.10
Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology (2002) 1.10
HBVdb: a knowledge database for Hepatitis B Virus. Nucleic Acids Res (2012) 1.09
Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods. J Health Econ (2004) 1.09
An economic evaluation of operative compared with nonoperative management of displaced intra-articular calcaneal fractures. J Bone Joint Surg Am (2005) 1.07
Hepatitis B virus infection from an evolutionary point of view: how viral, host, and environmental factors shape genotypes and subgenotypes. Infect Genet Evol (2011) 1.07
What needs to be done in contingent valuation: have Smith and Sach missed the boat? Health Econ Policy Law (2010) 1.07
Systematic review of stroke thrombolysis service configuration. Expert Rev Neurother (2009) 1.05
Overcoming barriers to priority setting using interdisciplinary methods. Health Policy (2009) 1.00
Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Med Decis Making (2007) 1.00
Willingness to pay for public health care: a comparison of two approaches. Health Policy (2004) 0.99
Valuing the benefits of weight loss programs: an application of the discrete choice experiment. Obes Res (2004) 0.98
Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J (2002) 0.97
Choosing the method to match the perspective: economic assessment and its implications for health-services efficiency. Lancet (2002) 0.95
Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care. Health Econ (2003) 0.95
Willingness to pay for a QALY: past, present and future. Expert Rev Pharmacoecon Outcomes Res (2008) 0.95
Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA. Antimicrob Agents Chemother (2008) 0.95
Should we use willingness to pay to elicit community preferences for health care? New evidence from using a 'marginal' approach. J Health Econ (2002) 0.93
Issues arising from the use of qualitative methods in health economics. J Health Serv Res Policy (2004) 0.93
Microarray for hepatitis B virus genotyping and detection of 994 mutations along the genome. J Clin Microbiol (2010) 0.92
Using participatory action research to build a priority setting process in a Canadian Regional Health Authority. Soc Sci Med (2006) 0.92
Estimating a WTP-based value of a QALY: the 'chained' approach. Soc Sci Med (2013) 0.91
Evaluation of the impact of program budgeting and marginal analysis in Vancouver Island Health Authority. J Health Serv Res Policy (2009) 0.90
Paying for treatments? Influences on negotiating clinical need and decision-making for dental implant treatment. BMC Health Serv Res (2009) 0.90
Acoustic-phonetic characteristics of speech produced with communicative intent to counter adverse listening conditions. J Acoust Soc Am (2011) 0.90
Modelling the monetary value of a QALY: a new approach based on UK data. Health Econ (2009) 0.89
Commissioning NHS dentistry in England: issues for decision-makers managing the new contract with finite resources. Health Policy (2008) 0.88
Role for the RecBCD recombination pathway for pilE gene variation in repair-proficient Neisseria gonorrhoeae. J Bacteriol (2007) 0.88
Functional analysis of the C-terminal domains of the site-specific recombinases XerC and XerD. J Mol Biol (2003) 0.88
The new myth: the social value of the QALY. Pharmacoeconomics (2008) 0.88
Decision maker views on priority setting in the Vancouver Island Health Authority. Cost Eff Resour Alloc (2008) 0.87
Identification of novel recombinants of hepatitis B virus genotypes F and G in human immunodeficiency virus-positive patients from Argentina and Brazil. J Gen Virol (2012) 0.87
A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus. J Gen Virol (2005) 0.87
Catastrophic healthcare payments and impoverishment in the occupied Palestinian territory. Appl Health Econ Health Policy (2010) 0.87
Case study on priority setting in rural Southern Alberta: keeping the house from blowing in. Can J Rural Med (2004) 0.86
Implementing world class commissioning competencies. J Health Serv Res Policy (2012) 0.85
The evolution of PBMA: towards a macro-level priority setting framework for health regions. Health Care Manag Sci (2003) 0.82
Breaking the addiction to technology adoption. Health Econ (2014) 0.82
Implicit versus explicit ranking: on inferring ordinal preferences for health care programmes based on differences in willingness-to-pay. J Health Econ (2005) 0.82
A stated preference approach to assessing health care-quality improvements in Palestine: from theoretical validity to policy implications. J Health Econ (2004) 0.82
Do ordering effects matter in willingness-to-pay studies of health care? J Health Econ (2002) 0.82
Improved rolling circle amplification (RCA) of hepatitis B virus (HBV) relaxed-circular serum DNA (RC-DNA). J Virol Methods (2013) 0.82
To reuse or not to reuse? An economic evaluation of hemodialyzer reuse versus conventional single-use hemodialysis for chronic hemodialysis patients. Int J Technol Assess Health Care (2002) 0.82
Listening to the decision makers: sustainability of PBMA in Alberta. Appl Health Econ Health Policy (2004) 0.82
Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis framework. Expert Rev Pharmacoecon Outcomes Res (2010) 0.82
Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape. J Infect Dis (2012) 0.82
Autonomy, special offers and routines: a Q methodological study of industry-driven marketing influences on young people's drinking behaviour. Addiction (2014) 0.82
Resource allocation in health care: health economics and beyond. Health Care Anal (2003) 0.81
Valuing food safety improvements using willingness to pay. Appl Health Econ Health Policy (2003) 0.81
Comparing WTP values of different types of QALY gain elicited from the general public. Health Econ (2013) 0.81
Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic review. Cost Eff Resour Alloc (2013) 0.81
HDV genotypes in the Western Brazilian Amazon region: A preliminary report. Am J Trop Med Hyg (2006) 0.81
Q-ing for health--a new approach to eliciting the public's views on health care resource allocation. Health Econ (2013) 0.80
Priority-setting in health authorities: moving beyond the barriers. The Calgary experience. Healthc Q (2005) 0.80
The costs and benefits of community thrombolysis for acute myocardial infarction : a decision-analytic model. Pharmacoeconomics (2004) 0.80
Understanding public preferences for prioritizing health care interventions in England: does the type of health gain matter? J Health Serv Res Policy (2011) 0.80
Discrete choice experiments in health economics: distinguishing between the method and its application. Eur J Health Econ (2005) 0.80
Resource allocation in orthopaedics: economic evaluation to priority setting. Clin Orthop Relat Res (2007) 0.80
Managing resources in NHS dentistry: using health economics to inform commissioning decisions. BMC Health Serv Res (2011) 0.80
Decision maker perceptions of resource allocation processes in Canadian health care organizations: a national survey. BMC Health Serv Res (2013) 0.80
Use of the U.S. and U.K. scoring algorithm for the EuroQol-5D in an economic evaluation of cardiac care. Med Care (2007) 0.80
Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective. J Rheumatol (2005) 0.79
CRIB--the use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial (RCT) with embedded feasibility study. BMJ Open (2014) 0.79